Latest Capital Markets News

Marimaca Copper Corp. has issued a prospectus for a nominal cleansing offer of 100 new CDIs at A$10.65 each, aiming to remove trading restrictions on previously issued securities. The company also disclosed extensive risk factors, including ongoing legal proceedings and project development uncertainties.

Rapid Critical Metals Limited (ASX, RCM) has unveiled a strategic acquisition of two high-grade silver projects in New South Wales and a critical metals project in British Columbia, supported by a proposed $10 million capital raise.

Almonty Industries has successfully priced a US$90 million upsized public offering and commenced trading on the Nasdaq, positioning itself as a key tungsten supplier for U.S. defense needs.

Larvotto Resources is exploring a USD 100 million senior secured bond to finance the restart of its Hillgrove Antimony and Gold Project, signaling a major step in advancing its mineral portfolio.

Dundee Precious Metals has published the detailed scheme document for its recommended acquisition of Adriatic Metals, setting the stage for shareholder votes in August 2025. The transaction, subject to regulatory approvals, aims to consolidate two key players in the precious metals mining sector.

Broken Hill Mines Limited has completed its acquisition of Broken Hill Mines Holdings Pty Ltd, restructured its board, and is preparing for a trading reinstatement on the ASX under the ticker 'BHM'.

Viridis Mining promotes CEO Rafael Moreno to Managing Director as the Colossus Rare Earth Project advances toward production, marking a strategic leadership shift amid key development milestones.

ikeGPS has successfully raised A$18 million through a fully underwritten placement, supported by strong investor demand, and is launching a A$2 million share purchase plan to fund new product development and strategic initiatives.

Eastern Metals updates its proposed acquisition of Raptor Resources, shifting to a takeover bid or scheme of arrangement, alongside a $4-5 million capital raise via share placement.

Pacific Edge reports steady demand for its Cxbladder cancer diagnostic tests despite losing Medicare coverage and transitioning US customers to a new test. The company is advancing clinical evidence and a $21 million capital raise to support growth and regain coverage.

Australian Strategic Materials unveils a transformative heap leach approach for its Dubbo Project, cutting upfront capital costs by over half and accelerating rare earth oxide production amid rising global demand.

Cambium Bio has secured FDA clearance to begin Phase 3 dosing of Elate Ocular, a promising treatment for moderate to severe dry eye disease, pending additional financing.